Published within
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
»
»|
| Type |
Product title / description
|
Pub
|
Price |
Report
|
In the wake of Lipitor’s patent expiry, the dyslipidemia market continues to face increasing genericization leading to falling sales in key drug classes.
Published By Datamonitor
|
04 Feb 2013 |
$4500
|
Report
|
This report provides an analysis of the orphan drug market. It comprises brands that have gained US FDA orphan drug approval, as well as Phase III pipeline candidates that have gained an orphan drug designation from the FDA.
Published By Datamonitor
|
08 Jan 2013 |
$3500
|
Report
|
Datamonitor provides an overview of and profiles key hemophilia A and B pipeline products launching in the near future in the US and five major EU markets (France, Germany, Italy, Spain, and the UK).
Published By Datamonitor
|
12 Nov 2012 |
$3800
|
Report
|
This report provides analysis of key oral anticoagulants brands and pipeline agents for stroke prevention in atrial fibrillation (SPAF) across the seven major markets, including a comparative evaluation of clinical and commercial drug attributes.
Published By Datamonitor
|
22 Aug 2012 |
$11400
|
Report
|
Datamonitor profiles leading, currently marketed non-insulin brands as well as pipeline products launching in the near future. Coverage: the US, Japan, France, Germany, Italy, Spain, and the UK.
Published By Datamonitor
|
14 Aug 2012 |
$7600
|
Report
|
This report provides detailed dyslipidemia treatment paths based on a survey of 51 Chinese primary care physicians across different cities, with analysis of patient potential, patient segments, prescribing patterns, and leading treatment regimens.
Published By Datamonitor
|
15 Jun 2012 |
$5700
|
Report
|
Datamonitor patient-based forecast of leading non-insulin brands and pipeline products for 2011 to 2020. Coverage: US, Japan, France, Germany, Italy, Spain, and the UK.
Published By Datamonitor
|
29 May 2012 |
$11400
|
Report
|
Overview of stroke and atrial fibrillation definitions and a review of the epidemiology literature. This report provides in-depth analysis of patient populations, a 10-year incident case forecast, and key patient segments in the seven major markets.
Published By Datamonitor
|
17 May 2012 |
$3800
|
Report
|
This report provides detailed dyslipidemia treatment paths based on a survey of 125 primary care physicians across the seven major markets, with analysis of patient potential, patient segments, prescribing patterns, and leading treatment regimens.
Published By Datamonitor
|
08 May 2012 |
$7600
|
Report
|
In-depth analysis of key insulin brands and pipeline agents indicated for the treatment of type 1 and type 2 diabetes. Provides a comparative evaluation of clinical and commercial drug attributes to determine competitiveness in the marketplace.
Published By Datamonitor
|
27 Apr 2012 |
$7600
|
|«
«
|
1
|
2
|
3
|
4
|
5
|
6
|
»
»|
No help is available.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Business Insight reports are an objective source of data, analysis and market insight
Insight for technology vendors into customer trends and pain points from key business decision makers.
Butler Group's thought leadership, opinion, with end user case studies and product profiles for key vendors.
Butler Group's vendor ranking and assessment model groups vendors into Outperform, Perform, and Under-perform categories.
Butler Group's thought leadership, opinion, and best practice with technology audits, product comparisons and rankings.
Opinion and market commentary from Datamonitor's industry experts.
Company profiles deliver detailed insight into how companies are organized and function with SWOT analysis.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Company reports provide detailed company evaluations.
Opinion and market commentary from Datamonitor's industry experts.
Opinion and market commentary from Datamonitor's industry experts.
Track industry events, markets, products, customers, prospects, competitors and partners
Country profiles presenting easy-to-digest summaries and standardized data.
Databooks use charts and tables to provide a data-centric view of a particular market or category
Opinion and market commentary from Datamonitor's industry experts.
Comprehensive category data, including market value, volume, segmentation and share, with analysis.
Industry profiles provide standardized market data (including size & segmentation) and competitive analysis.
Market sizing and forecast data for a market or sector delivered in spreadsheet format.
Track industry events, markets, products, customers, prospects, competitors and partners
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Ovum's research addresses the commercial impact of technology and market changes in telecoms, software and IT services.
Reports and briefs contain analyst driven analysis and opinion covering a specific market or issue.
Opinion and market commentary from Datamonitor's industry experts.
Insight for technology vendors into customer trends and pain points from key business decision makers.
Business information covering a specific market or issue.